Wei Yuan, Liu Chaoqun, Lai Fangfang, Dong Shan, Chen Haiyan, Chen Li, Shi Liping, Zhu Fengfeng, Zhang Chuangbiao, Lv Xiuxiu, Peng Shuang, Hao Guang
Center for Scientific Research and Institute of Exercise and Health, Guangzhou Sport University, Guangzhou, 510500, China.
Department of Nutrition, School of Medicine, Jinan University, Guangzhou, 510632, China.
Diabetol Metab Syndr. 2021 Dec 7;13(1):143. doi: 10.1186/s13098-021-00762-0.
This study aims to examine the cross-sectional association between serum total bilirubin (STB) and type 2 diabetes (T2D) risk in the general population, and whether obesity could moderate this association.
We used data from the 1999-2018 National Health and Nutrition Examination Surveys (NHANES), including a total of 38,641 US adult participants who were 18 years or older. The STB was classified as the low, moderate, and high groups according to tertiles.
We found that participants with lower STB had a significantly higher risk of T2D than those with moderate (OR = 0.81; 95% CI 0.74, 0.89; P < 0.001) and high (OR = 0.65; 95% CI 0.59, 0.73; P < 0.001) STB. Also, a significant interaction between body mass index (BMI) and STB on T2D was observed (P < 0.001). Stratified analysis showed that low STB was associated with a 20% and 27% decrease of T2D risk for moderate and high STB groups in obese patients, however, these effect estimates were smaller in the population with lower BMI (< 30 kg/m). Similar associations of STB with glycohemoglobin and insulin resistance were observed.
This study suggests that STB is associated with an elevated risk of T2D. More importantly, we reported for the first time that BMI may moderate the association between bilirubin and T2D.
本研究旨在探讨普通人群中血清总胆红素(STB)与2型糖尿病(T2D)风险之间的横断面关联,以及肥胖是否会影响这种关联。
我们使用了1999 - 2018年美国国家健康与营养检查调查(NHANES)的数据,其中共有38641名18岁及以上的美国成年参与者。根据三分位数将STB分为低、中、高组。
我们发现,与STB处于中等水平(OR = 0.81;95%CI 0.74,0.89;P < 0.001)和高水平(OR = 0.65;95%CI 0.59,0.73;P < 0.001)的参与者相比,STB水平较低的参与者患T2D的风险显著更高。此外,观察到体重指数(BMI)与STB之间在T2D方面存在显著的交互作用(P < 0.001)。分层分析显示,低STB与肥胖患者中STB处于中等和高水平组的T2D风险分别降低20%和27%相关,然而,在BMI较低(< 30 kg/m²)的人群中,这些效应估计值较小。观察到STB与糖化血红蛋白和胰岛素抵抗之间存在类似的关联。
本研究表明,STB与T2D风险升高相关。更重要的是,我们首次报道BMI可能会影响胆红素与T2D之间的关联。